Medigus in Advanced Negotiations to License its MUSE™ Technology

Medigus (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that it is in advanced negotiations to grant a license or licenses to its MUSE™ technology Globally and/or in greater China.

As quoted in the press release:

For this purpose, Medigus commenced advanced talks with relevant multi-national medical device companies and is expected to receive upfront payments that may add up to millions of U.S. dollars should such transactions close.

Such transactions will be subject to the completion and execution of mutually acceptable definitive agreement and the satisfaction of closing conditions to be contained therein.

Medigus’ efforts to sell a license or licenses to the MUSE™ technology are further to the decision of its board of directors to create immediate value to the Company and its shareholders in the various operation fields of the Company by optimizing the Company’s operations, decreasing the ordinary course expenses and creating an immediate significant and positive cash flow.

Click here to read the full press release.